Responsible for assisting and/or leading the development and, implementation of regulatory strategies for assigned products across a range of therapeutic areas, which may include both in-development (brand and generic) and marketed products. Support priority projects with limited supervision and lead other regulatory related activities (i.e. FDA milestone meetings, regulatory risk assessments, core development team meetings, etc.).
Participate and lead activities for the Regulatory Intelligence program for global regulatory affairs. The regulatory intelligence program consists of researching, analyzing, interpreting, communicating and acting on intelligence relative to the regulatory landscape, submission routes and existing and/or emerging competitor products to drive compliance and competitive advantage.
Demonstrate excellent leadership, communications, and interpersonal skills. Knowledge of regulatory requirements, guidance and regulations (US and international) within the pharmaceutical industry is desirable, knowledge specific to the Noven areas of clinical research and product development is desirable. Experience with IND and/or NDA/NDAs/ANDAs filings, general submissions along with Regulatory Intelligence activities is highly desirable.
A minimum BS/BA Degree preferably in life sciences. A higher degree (Masters, PhD, PharmD) and/or RAC certification is preferred. At least 3-5 years regulatory or related experience in pharmaceutical industry.
Office setting, ergonomic cubicle workspace, laptop and desktop provided
Ability to utilize computer in seated or standing position

Noven Pharmaceuticals, Inc. is a dynamic specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. We are committed to developing and offering pharmaceutical products that meaningfully benefit patients, with a commitment to advancing patient care through transdermal drug delivery.
Over 300 Noven colleagues are working to advance our business and benefit patients at locations in Miami, FL, Jersey City, NJ. We are a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world’s largest manufacturer of transdermal patches, and we serve as Hisamitsu's growth platform for U.S. prescription pharmaceuticals.
Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami with capacity to produce several hundred million patches per year. These facilities are also approved by the U.S. DEA (Drug Enforcement Agency) for the production of controlled substances.